Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Smruthi Organics Limited specializes in the production of pharmaceutical intermediates and active pharmaceutical ingredients (APIs), primarily serving the Indian and international markets. The company differentiates itself through its focus on high-quality manufacturing processes and a diverse product portfolio that includes over 50 APIs, catering to various therapeutic segments.
Smruthi Organics generates revenue through the sale of pharmaceutical intermediates and APIs, leveraging its strong relationships with generic drug manufacturers. The company benefits from pricing power due to its reputation for quality and compliance with international regulatory standards, which allows it to maintain margins despite competitive pressures.
Changes in regulatory approvals for new APIs
Fluctuations in raw material costs, particularly for key inputs like solvents and reagents
Demand shifts in the generic pharmaceuticals market
New contract wins in contract manufacturing
Regulatory changes impacting the pharmaceutical industry, particularly in export markets
Technological disruption in drug manufacturing processes
Increased competition from low-cost manufacturers in Asia
Potential loss of market share to larger pharmaceutical companies with more extensive R&D budgets
Low liquidity risk due to a current ratio of 1.98, but reliance on cash flow generation for future growth
Potential risks associated with currency fluctuations affecting export revenues
moderate - the pharmaceutical industry is somewhat insulated from economic downturns, but demand for non-essential drugs may decline during recessions.
Low - the company has minimal debt (Debt/Equity of 0.11), so rising interest rates have limited impact on financing costs, but could affect overall market valuations.
minimal - Smruthi Organics does not rely heavily on credit for operations, given its low debt levels.
value - the company's low valuation metrics (P/S of 1.3x) and stable cash flows appeal to value investors.
moderate - historical volatility is around 1.2, indicating some sensitivity to market movements.